- Science
- Clinical Trials
- Guide to Clinical Trials Your participation makes a difference
- Clinical Trials in Children Designed to improve kids' health
- Data and Results Sharing our Results
- Integrity and Transparency Building Trust
- Diversity Equity and Representation
- Plain Language Study Results Trial Result Summaries
- Expanded Access & Compassionate Use Possible Treatment Options
- Find a Trial
- Areas of Focus
- Rare Disease Smaller populations but big impact
- Internal Medicine Extending lifespans worldwide
- Inflammation & Immunology Treatment at the molecular level
- Vaccines Preventing the spread of infections
- Oncology The science of optimism
- Anti Infectives Combatting an evolving risk
- Areas of Innovation
- Gene Therapy Breakthroughs become treatments
- Medicinal Sciences The next generation of science
- Precision Medicine Developing tailored medicines
- Maternal Immunization Protecting newborns at the start
- mRNA Technology Unleashing the next wave of scientific innovations
- Diseases & Conditions
- Coronavirus Resources
- Product Pipeline
- Research Sites
- Clinical Trials
- Products
- How Drugs are Made
- Branded vs. Generic Learn the difference
- Biologics & Biosimilars Cures found in nature
- Commitment to Quality Maintaining the highest standards
- Global Supply Strategic manufacturing locations
- Manufacturing Sites Where medicine is made in the U.S.
- Medicine Safety
- Health Literacy Learning to be well
- Treatment Choices Learning about treatment decisions
- Partnering With Patients Helping others by reporting side effects
- Tips for Patients Preventing medication errors
- Reporting Adverse Events
- Counterfeiting Preventing medication errors
- Product Safety
- Product List
- Product Contacts
- PfizerPro for Professionals
- Patient Assistance Programs
- Distributors
- How Drugs are Made
- Stories
- Newsroom
- About
- People
- Executives Our senior-most leadership
- Board Members The people steering our company
- Scientists Our experts making discoveries
- Patient Stories Our patients
- Colleague Stories Our colleagues
- Responsibility
- Ethics & Compliance Each of us is responsible
- Responsible Business Breakthroughs that change patients’ lives
- Patient Advocacy & Engagement Putting Patients First
- Global Impact Meeting urgent needs worldwide
- Diversity, Equity, and Inclusion Everyone has something to offer
- Environmental Sustainability Our responsiblity to the environment
- Human Rights Furthering dignity and worth
- Health & Safety
- Intellectual Property The benefits of fair competition
- EHS Governance
- Misinformation
- Programs & Policies
- Grants Support for independent research
- Political Partnership Supporting like-minded organizations
- Working with Healthcare Professionals Collaboration to improve lives
- Prescription Value & Pricing How to lower patient costs
- Privacy Principles Commitment to personal data privacy
- Ready for Cures Improving Access to Medicines
- Transparency in Grants Committed to Disclosure
- Policy Positions
- Investors
- Investors Overview Information for stockholders
- Why Invest Why to join us in our mission
- Events & Presentations Calendar of upcoming events
- Financial Reports Quarterly reports and more
- Investor News Announcements about our performance
- Stock Information Charts and data
- Shareholder Services Information on stock transactions
- Corporate Governance
- Corporate Governance Overview Gaining insight into our performance
- Board Committees & Charters Defining the corporate structure
- The Pfizer Board Policies Ensuring ethical leadership
- Corporate Governance FAQs Learn more about our approach
- Contact Our Directors Email any of our Directors
- Purpose
- History
- Careers
- Partners
- People
Change Lives for Generations to Come
Pfizer Owns Innovation
Whatever the disease, our 25,000 clinical researchers are turning advanced science and technologies into the therapies that matter most. Their efforts are one of the greatest human endeavors, impacting millions around the world.
At Pfizer, you can truly make progress happen through your work. You can redefine healthcare — and your own potential — at the same time. That’s because ours is a uniquely collaborative global community. It will see you work, learn, and innovate with the first-class talent around you, and around the world.It’s a collection of people with different ideas, experiences and points of view for you to draw on. With inspiration like that, you’re certain to grow and develop with Pfizer.
OUR THERAPEUTIC AREAS
2020 SCIENCE CAREERS TOP EMPLOYER
We are honored to be recognized as a 2020 Science Careers Top Employer. Thanks to our researchers and scientists, we're proud to support a culture where ideas can become breakthroughs that change patients' lives.
CARDIOVASCULAR DISEASES
Cardiovascular diseases are the number one cause of death worldwide. Our research focuses on investigating potential therapies that treat both the metabolic abnormalities and the heart itself by altering the way it responds to the abnormal metabolic state.
READ MORE
Rare disease
Our rare disease team concentrates on therapies for rare disorders. They explore many innovative avenues, including gene therapy and more. Click here to read about the work.
READ MORE
Vaccines
Vaccines are one of the greatest public health advancements of all time. Here, our team translates cutting-edge science into next-generation vaccines. Click here to learn about our vaccines R&D career opportunities.
Read More about Vaccines
Oncology
Our oncology team looks to transform the cancer treatment landscape through meaningful breakthroughs and a robust pipeline of novel cancer medicines. There’s more here.
Read moreHow We're Innovating Now
Whether it’s leading the way with gene therapy, using breakthrough science to transform cancer treatment, or developing novel anti-infective therapies, we’re right at the cutting edge. We’re even using ‘molecular glues’ and breaking the rules of biology. That determination to do things differently is powering our pipeline: we currently have 100 compounds in development, and 37 of those are in Phase 3 trials or registration.
New Therapies
We don’t simply have an eye on the future. We’re creating it. New technology is helping us redefine how we approach the R&D process, we’re developing advanced biotherapeutic medicines that can evade detection by the immune system, and our teams are designing and creating molecules that can change the function of a potential target. Different expertise is essential in innovation, as Jennifer Lafontaine explains here.
READ MORE DetailsWorking Better Together
Research partnerships, networks and collaborations allow innovation to thrive. We know we can’t do it alone, so we’re working with everyone from the government and academia to some of our biggest biopharma competitors to get our innovations to patients fast. Our Centers for Therapeutic Innovation (CTI) bridge academia and industry, and we support independent research and quality improvement initiatives to power our guiding purpose – improving patient outcomes.
A Robust Product Pipeline
We’re addressing unmet needs in areas including Oncology, Inflammation & Immunology, Vaccines, Internal Medicine and Rare Disease. Of the 100 products currently in our pipeline, 35 are in Phase 1, 28 in Phase 2, 26 in Phase 3 and 11 are at registration stage. They range from vaccines to small molecule to biologic, and are designed to treat diseases from streptococcal infections to prostate cancer.
Whatever your scientific field, you’ll find your place and feel your impact on global healthcare with us at Pfizer. Learn more about our US R&D sites in the navigation.
Research & Development
View the latest career opportunities in the Research & Development groups.